triazoles has been researched along with gsk2194069 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briand, J; Brown, KK; Burkhart, WA; Hardwicke, MA; Krueger, JA; Moore, ML; Parrish, CA; Plant, RN; Rendina, AR; Totoritis, RD; Wang, L; Williams, SP; Zhang, G | 1 |
| Bergthaler, A; Bigenzahn, JW; César-Razquin, A; Kartnig, F; Kornauth, C; Lercher, A; Pemovska, T; Srndic, I; Staber, PB; Superti-Furga, G; Valent, P | 1 |
2 other study(ies) available for triazoles and gsk2194069
| Article | Year |
|---|---|
A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase; Catalytic Domain; Cell Line, Tumor; Enzyme Inhibitors; Fatty Acid Synthases; Humans; Models, Molecular; Protein Conformation; Pyrrolidines; Triazoles; X-Ray Diffraction | 2014 |
Metabolic drug survey highlights cancer cell dependencies and vulnerabilities.
Topics: Biomarkers, Tumor; Cell Survival; Cluster Analysis; Fatty Acids; Genotype; Humans; Leukemia, Myeloid; Monocarboxylic Acid Transporters; Phenotype; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Pyrimidinones; Pyrrolidines; Signal Transduction; Small Molecule Libraries; Symporters; Systems Analysis; Thiophenes; Triazoles; Tumor Cells, Cultured | 2021 |